Indication
PPOS
1 clinical trial
2 products
Clinical trial
A Randomized Control Trial to Compare the Live Birth Rate Between the Progestin-primed Ovarian Stimulation Protocol and the GnRH Antagonist Protocol in Patients With Anticipated High Ovarian Response Undergoing IVFStatus: Completed, Estimated PCD: 2022-10-10
Product
ProgesteroneProduct
GnRH Antagonist